First-line therapies for hypertension and heart failure include antihypertensive agents, such as Angiotensin-Converting Enzyme inhibitors (ACE) inhibitors and Angiotensin Receptor Blockers (ARBs), which reduce cardiovascular events [52,53]. This evidence concerns the gene ACE and hypertensive disorder.